The risk or severity of adverse effects can be increased when amitriptyline is combined with felbamate.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with Tianeptine.


The risk or severity of adverse effects can be increased when Icatibant is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with cilazapril.


The risk or severity of adverse effects can be increased when spironolactone is combined with sotalol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with losartan.


The risk or severity of adverse effects can be increased when zotepine is combined with scopolamine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with hydromorphone.


The risk or severity of adverse effects can be increased when butalbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Naftifine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Masoprocol is combined with prednisone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when sulindac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when diclofenac is combined with antipyrine.


The risk or severity of adverse effects can be increased when oxycodone is combined with indapamide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with amoxapine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when haloprogin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when glimepiride is combined with leflunomide.


The risk or severity of adverse effects can be increased when moclobemide is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when prilocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Olopatadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Olmesartan.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when zotepine is combined with tizanidine.


The risk or severity of adverse effects can be increased when enalapril is combined with floctafenine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when cocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with cilazapril.


The risk or severity of adverse effects can be increased when triazolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when valsartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when nabumetone is combined with carprofen.


The risk or severity of adverse effects can be increased when clorazepate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Difenoxin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Normethadone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Butethal.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when olanzapine is combined with amobarbital.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when miconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when miconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when miconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when butalbital is combined with clidinium.


The risk or severity of adverse effects can be increased when miconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with fludiazepam.


The risk or severity of adverse effects can be increased when miconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with scopolamine.


The risk or severity of adverse effects can be increased when alclometasone is combined with memantine.


The risk or severity of adverse effects can be increased when isoflurane is combined with D-mannitol.


The risk or severity of adverse effects can be increased when alclometasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when ethanol is combined with pargyline.


The risk or severity of adverse effects can be increased when RUCAPARIB is combined with atorvastatin.


The risk or severity of adverse effects can be increased when methotrexate is combined with clozapine.


The risk or severity of adverse effects can be increased when maprotiline is combined with desipramine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when prazosin is combined with papaverine.


The risk or severity of adverse effects can be increased when prazosin is combined with nifedipine.


The risk or severity of adverse effects can be increased when cilazapril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Phenelzine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when triazolam is combined with procaine.


The risk or severity of adverse effects can be increased when triazolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when oxymorphone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when clidinium is combined with paroxetine.


The risk or severity of adverse effects can be increased when spironolactone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when amcinonide is combined with malathion.


The risk or severity of adverse effects can be increased when spironolactone is combined with bumetanide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with scopolamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Etomidate.


The risk or severity of adverse effects can be increased when isoflurane is combined with bupivacaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with amobarbital.


The risk or severity of adverse effects can be increased when pergolide is combined with haloperidol.


The risk or severity of adverse effects can be increased when pergolide is combined with ritonavir.


The risk or severity of adverse effects can be increased when trandolapril is combined with indomethacin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with quinidine.


The risk or severity of adverse effects can be increased when flurazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with edrophonium.


The risk or severity of adverse effects can be increased when baclofen is combined with levodopa.


The risk or severity of adverse effects can be increased when Talniflumate is combined with epirizole.


The risk or severity of adverse effects can be increased when doxylamine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with maprotiline.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with trazodone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when loxapine is combined with thiopental.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Articaine is combined with citalopram.


The risk or severity of adverse effects can be increased when Fosamprenavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when Normethadone is combined with desipramine.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when triazolam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when triazolam is combined with levodopa.


The risk or severity of adverse effects can be increased when procaine is combined with halothane.


The risk or severity of adverse effects can be increased when metaproterenol is combined with nylidrin.


The risk or severity of adverse effects can be increased when nabumetone is combined with DESONIDE.


The risk or severity of adverse effects can be increased when procaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when metolazone is combined with carvedilol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Bretylium.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Etomidate is combined with scopolamine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with baclofen.


The risk or severity of adverse effects can be increased when cisplatin is combined with leflunomide.


The risk or severity of adverse effects can be increased when pramipexole is combined with D-mannitol.


The risk or severity of adverse effects can be increased when triazolam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when olanzapine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with etizolam.


The risk or severity of adverse effects can be increased when acemetacin is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when acemetacin is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when propantheline is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when pancuronium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when ketamine is combined with trazodone.


The risk or severity of adverse effects can be increased when risperidone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with malathion.


The risk or severity of adverse effects can be increased when propofol is combined with ketamine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when benzphetamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with clonazepam.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with promethazine.


The risk or severity of adverse effects can be increased when methazolamide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with terazosin.


The risk or severity of adverse effects can be increased when medrysone is combined with ambenonium.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with doxepin.


The risk or severity of adverse effects can be increased when trazodone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when flumethasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when isoniazid is combined with acetaminophen.


The risk or severity of adverse effects can be increased when clozapine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when clozapine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with sertraline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when protriptyline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when penbutolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when valsartan is combined with bumetanide.


The risk or severity of adverse effects can be increased when valsartan is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when valsartan is combined with quinapril.


The risk or severity of adverse effects can be increased when valsartan is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when chloroquine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when sertraline is combined with loxapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with trandolapril.


The risk or severity of adverse effects can be increased when haloperidol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when bromazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Retigabine.


The risk or severity of adverse effects can be increased when nystatin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when moclobemide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when metolazone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when antipyrine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Tramadol is combined with HEROIN.


The risk or severity of adverse effects can be increased when mesalamine is combined with alclometasone.


The risk or severity of adverse effects can be increased when indapamide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when quinapril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with paroxetine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with zotepine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Pregabalin.


The risk or severity of adverse effects can be increased when bifonazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with thiamylal.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with clidinium.


The risk or severity of adverse effects can be increased when morphine is combined with brotizolam.


The risk or severity of adverse effects can be increased when propofol is combined with triamterene.


The risk or severity of adverse effects can be increased when ketorolac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with tetracaine.


The risk or severity of adverse effects can be increased when morniflumate is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with triprolidine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with tetracaine.


The risk or severity of adverse effects can be increased when morphine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when amcinonide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when tetracaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with desipramine.


The risk or severity of adverse effects can be increased when Retigabine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Salsalate is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Salsalate is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Halazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when Halazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Salsalate is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when midazolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when barnidipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when pimozide is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with isoproterenol.


The risk or severity of adverse effects can be increased when equilin is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Limaprost is combined with Dabigatran etexilate.


The risk or severity of adverse effects can be increased when nilvadipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when trimeprazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when equilin is combined with malathion.


The risk or severity of adverse effects can be increased when quetiapine is combined with benzocaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with promethazine.


The risk or severity of adverse effects can be increased when dyclonine is combined with clonazepam.


The risk or severity of adverse effects can be increased when dibucaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when dyclonine is combined with Melatonin.


The risk or severity of adverse effects can be increased when isradipine is combined with fosinopril.


The risk or severity of adverse effects can be increased when protriptyline is combined with clomipramine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with donepezil.


The risk or severity of adverse effects can be increased when apomorphine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with manidipine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Lacidipine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with bezafibrate.


The risk or severity of adverse effects can be increased when nitric oxide is combined with lisinopril.


The risk or severity of adverse effects can be increased when diclofenac is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Benidipine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Phenelzine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when meperidine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Apremilast is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when meperidine is combined with estazolam.


The risk or severity of adverse effects can be increased when cabergoline is combined with clotiazepam.


The risk or severity of adverse effects can be increased when Isometheptene is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when zopiclone is combined with amobarbital.


The risk or severity of adverse effects can be increased when zopiclone is combined with Butethal.


The risk or severity of adverse effects can be increased when zopiclone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when zopiclone is combined with lithium ion.


The risk or severity of adverse effects can be increased when difluprednate is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with efavirenz.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Tramadol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when amobarbital is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Desloratadine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when losartan is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when triamterene is combined with carvedilol.


The risk or severity of adverse effects can be increased when methadone is combined with butamben.


The risk or severity of adverse effects can be increased when gabapentin is combined with baclofen.


The risk or severity of adverse effects can be increased when carisoprodol is combined with felbamate.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when gabapentin is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when losartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when zaleplon is combined with Butethal.


The risk or severity of adverse effects can be increased when rasagiline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when morphine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when pimozide is combined with Melatonin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when pimozide is combined with clonazepam.


The risk or severity of adverse effects can be increased when acemetacin is combined with prednisone.


The risk or severity of adverse effects can be increased when rasagiline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when acemetacin is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when phenindione is combined with Nintedanib.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when thiamylal is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when thiamylal is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when cetirizine is combined with clonazepam.


The risk or severity of adverse effects can be increased when cetirizine is combined with promethazine.


The risk or severity of adverse effects can be increased when methylene blue is combined with dobutamine.


The risk or severity of adverse effects can be increased when salicylamide is combined with loteprednol.


The risk or severity of adverse effects can be increased when carbamazepine is combined with tiapride.


The risk or severity of adverse effects can be increased when carbamazepine is combined with thiopental.


The risk or severity of adverse effects can be increased when estazolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amisulpride is combined with baclofen.


The risk or severity of adverse effects can be increased when Lacidipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when oxazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when prilocaine is combined with clemastine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Droxicam.


The risk or severity of adverse effects can be increased when polythiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when Efonidipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Tramadol is combined with Paliperidone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when amifostine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when amobarbital is combined with propoxyphene.


The risk or severity of adverse effects can be increased when morphine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with dyclonine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nicergoline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when phentolamine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when temazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nicergoline is combined with tioconazole.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when meprobamate is combined with efavirenz.


The risk or severity of adverse effects can be increased when triazolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with zotepine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when quazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with captopril.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when L-tryptophan is combined with procarbazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Riociguat.


The risk or severity of adverse effects can be increased when levorphanol is combined with Asenapine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with phenytoin.


The risk or severity of adverse effects can be increased when Salsalate is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when diltiazem is combined with timolol.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when nitrazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when isradipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when indomethacin is combined with fenoprofen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when butamben is combined with clomipramine.


The risk or severity of adverse effects can be increased when enflurane is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when oxycodone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Nabilone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with enalapril.


The risk or severity of adverse effects can be increased when epirizole is combined with dexamethasone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with formestane.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when ondansetron is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when codeine is combined with rasagiline.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with tolazoline.


The risk or severity of adverse effects can be increased when oxycodone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when methazolamide is combined with cilazapril.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with quinapril.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with bumetanide.


The risk or severity of adverse effects can be increased when nicergoline is combined with mefloquine.


The risk or severity of adverse effects can be increased when nicergoline is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when diclofenac is combined with diflunisal.


The risk or severity of adverse effects can be increased when nicergoline is combined with methylergonovine.


The risk or severity of adverse effects can be increased when topiramate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with butalbital.


The risk or severity of adverse effects can be increased when tretinoin is combined with benazepril.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with fenbufen.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Perospirone is combined with ethotoin.


The risk or severity of adverse effects can be increased when tiagabine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when bumetanide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Desloratadine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with mepivacaine.


The risk or severity of adverse effects can be increased when triamterene is combined with hydralazine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Pramocaine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Perospirone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with lansoprazole.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Propiverine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with tizanidine.


The risk or severity of adverse effects can be increased when celecoxib is combined with DESONIDE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with betamethasone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with loratadine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when nisoldipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when isradipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with amoxapine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when isradipine is combined with labetalol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when halothane is combined with tiapride.


The risk or severity of adverse effects can be increased when milrinone is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Cariprazine.


The risk or severity of adverse effects can be increased when indomethacin is combined with budesonide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when butorphanol is combined with levodopa.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when bumetanide is combined with digitoxin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when butorphanol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with etodolac.


The risk or severity of adverse effects can be increased when butorphanol is combined with baclofen.


The risk or severity of adverse effects can be increased when thiothixene is combined with fexofenadine.


The risk or severity of adverse effects can be increased when mesalamine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when antipyrine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Riociguat.


The risk or severity of adverse effects can be increased when Tapentadol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when midodrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with zopiclone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when reserpine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when gabapentin is combined with Remoxipride.


The risk or severity of adverse effects can be increased when rapamycin is combined with Benidipine.


The risk or severity of adverse effects can be increased when rapamycin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when benztropine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with gabapentin.


The risk or severity of adverse effects can be increased when mirtazapine is combined with isoetharine.


The risk or severity of adverse effects can be increased when butorphanol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when amoxapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when rapamycin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with formestane.


The risk or severity of adverse effects can be increased when rapamycin is combined with manidipine.


The risk or severity of adverse effects can be increased when diltiazem is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nabumetone is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when butorphanol is combined with quazepam.


The risk or severity of adverse effects can be increased when butorphanol is combined with prazepam.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with butalbital.


The risk or severity of adverse effects can be increased when resveratrol is combined with desoximetasone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with butamben.


The risk or severity of adverse effects can be increased when venlafaxine is combined with duloxetine.


The risk or severity of adverse effects can be increased when promazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when linezolid is combined with Iloperidone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with clidinium.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when prilocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when promazine is combined with clorazepate.


The risk or severity of adverse effects can be increased when sulpiride is combined with deslanoside.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with melphalan.


The risk or severity of adverse effects can be increased when amphotericin b is combined with captopril.


The risk or severity of adverse effects can be increased when Carbetocin is combined with pramipexole.


The risk or severity of adverse effects can be increased when cerulenin is combined with nimesulide.


The risk or severity of adverse effects can be increased when Tapentadol is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with levodopa.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with indapamide.


The risk or severity of adverse effects can be increased when clozapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when enflurane is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when midazolam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Nabilone is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Quinine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clonidine is combined with methazolamide.


The risk or severity of adverse effects can be increased when clomipramine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when prazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when enalapril is combined with azelastine.


The risk or severity of adverse effects can be increased when butorphanol is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when loratadine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with indapamide.


The risk or severity of adverse effects can be increased when loratadine is combined with flunarizine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Halazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when trazodone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with furazolidone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with losartan.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when sulfamethoxazole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when diazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when reserpine is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when nefazodone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with indapamide.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Escitalopram is combined with reserpine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Clevidipine.


The risk or severity of adverse effects can be increased when buspirone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Riociguat.


The risk or severity of adverse effects can be increased when buspirone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nifedipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with papaverine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when quinapril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with fludiazepam.


The risk or severity of adverse effects can be increased when quinapril is combined with nifedipine.


The risk or severity of adverse effects can be increased when quinapril is combined with papaverine.


The risk or severity of adverse effects can be increased when reserpine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when meperidine is combined with midazolam.


The risk or severity of adverse effects can be increased when trandolapril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when quetiapine is combined with etizolam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when butabarbital is combined with Perospirone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with acemetacin.


The risk or severity of adverse effects can be increased when enalapril is combined with epirizole.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with amitriptyline.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when prilocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when carprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when prilocaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Flupentixol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when methysergide is combined with Quinupristin.


The risk or severity of adverse effects can be increased when enflurane is combined with lithium ion.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when nefazodone is combined with amisulpride.


The risk or severity of adverse effects can be increased when ondansetron is combined with Fospropofol.


The risk or severity of adverse effects can be increased when enflurane is combined with Butethal.


The risk or severity of adverse effects can be increased when triazolam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with lisinopril.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with procaine.


The risk or severity of adverse effects can be increased when Tadalafil is combined with Udenafil.


The risk or severity of adverse effects can be increased when antipyrine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when barnidipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with meclizine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when morphine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with clonidine.


The risk or severity of adverse effects can be increased when oxazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when betaxolol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when nabumetone is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with oxaprozin.


The risk or severity of adverse effects can be increased when midazolam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when midazolam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with felodipine.


The risk or severity of adverse effects can be increased when sildenafil is combined with alprostadil.


The risk or severity of adverse effects can be increased when efavirenz is combined with meclizine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with irbesartan.


The risk or severity of adverse effects can be increased when perphenazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when midazolam is combined with levodopa.


The risk or severity of adverse effects can be increased when furazolidone is combined with domperidone.


The risk or severity of adverse effects can be increased when propofol is combined with methazolamide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Pazopanib.


The risk or severity of adverse effects can be increased when tiapride is combined with METAXALONE.


The risk or severity of adverse effects can be increased when estrone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when alprazolam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when salicylic acid is combined with bepridil.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with sotalol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Clobetasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Nabilone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Butethal.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with amobarbital.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when atenolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when suprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Clobetasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with salicylic acid.


The risk or severity of adverse effects can be increased when minoxidil is combined with triamterene.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with milrinone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when codeine is combined with tiapride.


The risk or severity of adverse effects can be increased when losartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when flurazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when flurazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when reserpine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mechlorethamine.


The risk or severity of adverse effects can be increased when buspirone is combined with dibucaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Metipranolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Torasemide.


The risk or severity of adverse effects can be increased when Asenapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when DESONIDE is combined with mefloquine.


The risk or severity of adverse effects can be increased when loxapine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with morphine.


The risk or severity of adverse effects can be increased when flurazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when mesalamine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when flurazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when fenoprofen is combined with leflunomide.


The risk or severity of adverse effects can be increased when midodrine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when protriptyline is combined with carisoprodol.


The risk or severity of adverse effects can be increased when pramipexole is combined with enalapril.


The risk or severity of adverse effects can be increased when protriptyline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when HEROIN is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when biperiden is combined with Pentolinium.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ketamine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when thioridazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when promethazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when isradipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with duloxetine.


The risk or severity of adverse effects can be increased when ethotoin is combined with citalopram.


The risk or severity of adverse effects can be increased when bromocriptine is combined with danazol.


The risk or severity of adverse effects can be increased when amifostine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when zotepine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when nitrendipine is combined with nadolol.


The risk or severity of adverse effects can be increased when promethazine is combined with sertraline.


The risk or severity of adverse effects can be increased when procaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when trazodone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Dothiepin is combined with terbutaline.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Cariprazine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tiapride is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Nabilone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pramipexole is combined with prazosin.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with diflorasone.


The risk or severity of adverse effects can be increased when azelastine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with cilazapril.


The risk or severity of adverse effects can be increased when Nabilone is combined with nadolol.


The risk or severity of adverse effects can be increased when secobarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when cetirizine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with doxepin.


The risk or severity of adverse effects can be increased when thiothixene is combined with amoxapine.


The risk or severity of adverse effects can be increased when thiothixene is combined with nortriptyline.


The risk or severity of adverse effects can be increased when mesoridazine is combined with phenytoin.


The risk or severity of adverse effects can be increased when vindesine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Voriconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when metoclopramide is combined with nefazodone.


The risk or severity of adverse effects can be increased when ethosuximide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with propofol.


The risk or severity of adverse effects can be increased when pancuronium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when equilin is combined with tubocurarine.


The risk or severity of adverse effects can be increased when HEROIN is combined with amitriptyline.


The risk or severity of adverse effects can be increased when HEROIN is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with sulindac.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when loxapine is combined with cocaine.


The risk or severity of adverse effects can be increased when loxapine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Etidocaine is combined with levodopa.


The risk or severity of adverse effects can be increased when loxapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Talniflumate is combined with chloroquine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when trazodone is combined with moclobemide.


The risk or severity of adverse effects can be increased when trazodone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Perospirone.


The risk or severity of adverse effects can be increased when trazodone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with 5-Fluorocytosine.


The risk or severity of adverse effects can be increased when estazolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when acemetacin is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when ketamine is combined with dibucaine.


The risk or severity of adverse effects can be increased when THYMOL is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with minoxidil.


The risk or severity of adverse effects can be increased when isoflurane is combined with Desloratadine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Diatrizoic acid is combined with metformin.


The risk or severity of adverse effects can be increased when isoflurane is combined with apraclonidine.


The risk or severity of adverse effects can be increased when propranolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when isoflurane is combined with zaleplon.


The risk or severity of adverse effects can be increased when irinotecan is combined with leflunomide.


The risk or severity of adverse effects can be increased when Vilazodone is combined with clomipramine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when sertraline is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with methyldopa.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Torasemide.


The risk or severity of adverse effects can be increased when promazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with terazosin.


The risk or severity of adverse effects can be increased when propofol is combined with doxepin.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with leflunomide.


The risk or severity of adverse effects can be increased when doxycycline is combined with Acitretin.


The risk or severity of adverse effects can be increased when amoxapine is combined with clidinium.


The risk or severity of adverse effects can be increased when medrysone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with atenolol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with olanzapine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with efavirenz.


The risk or severity of adverse effects can be increased when leflunomide is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when clonidine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when carprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tizanidine is combined with felbamate.


The risk or severity of adverse effects can be increased when cilnidipine is combined with betaxolol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Asenapine is combined with thiopental.


The risk or severity of adverse effects can be increased when aspirin is combined with prednisone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when aspirin is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when thioridazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when carprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when Asenapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nabumetone is combined with equilin.


The risk or severity of adverse effects can be increased when leflunomide is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when leflunomide is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with felbamate.


The risk or severity of adverse effects can be increased when flurazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Normethadone is combined with methazolamide.


The risk or severity of adverse effects can be increased when haloperidol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when diltiazem is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with dantrolene.


The risk or severity of adverse effects can be increased when loteprednol is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when butamben is combined with ethotoin.


The risk or severity of adverse effects can be increased when cetirizine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Lurasidone is combined with triprolidine.


The risk or severity of adverse effects can be increased when morphine is combined with diazepam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when oxiconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with estrone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with triazolam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with enoxacin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when olanzapine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when chloroquine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when olanzapine is combined with amoxapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when chloroquine is combined with amcinonide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when procaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when tolterodine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Pentolinium is combined with meperidine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when norepinephrine is combined with dobutamine.


The risk or severity of adverse effects can be increased when triazolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when bifonazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with butalbital.


The risk or severity of adverse effects can be increased when phentolamine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Imatinib is combined with clozapine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with tiapride.


The risk or severity of adverse effects can be increased when dibucaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when valsartan is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Halazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with dantrolene.


The risk or severity of adverse effects can be increased when Pipamperone is combined with cilazapril.


The risk or severity of adverse effects can be increased when dyclonine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ACENOCOUMAROL is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when methoxamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when labetalol is combined with nicotine.


The risk or severity of adverse effects can be increased when labetalol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when hydralazine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Lacidipine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when phenobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Droxicam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with triamterene.


The risk or severity of adverse effects can be increased when lidocaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when secobarbital is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when benazepril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when codeine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when indomethacin is combined with Droxicam.


The risk or severity of adverse effects can be increased when valsartan is combined with terazosin.


The risk or severity of adverse effects can be increased when resveratrol is combined with nimesulide.


The risk or severity of adverse effects can be increased when codeine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when indomethacin is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when triprolidine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when indomethacin is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when flurazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when procarbazine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when procarbazine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when sulindac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when dicyclomine is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when phenobarbital is combined with baclofen.


The risk or severity of adverse effects can be increased when Asenapine is combined with Perospirone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with fenbufen.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Amrinone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Conivaptan is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when morphine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with clomipramine.


The risk or severity of adverse effects can be increased when pergolide is combined with oxybutynin.


The risk or severity of adverse effects can be increased when promethazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when promethazine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Torasemide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Torasemide is combined with bumetanide.


The risk or severity of adverse effects can be increased when rasagiline is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Torasemide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Torasemide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Torasemide is combined with quinapril.


The risk or severity of adverse effects can be increased when butabarbital is combined with butamben.


The risk or severity of adverse effects can be increased when midazolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when pergolide is combined with methadone.


The risk or severity of adverse effects can be increased when midazolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Perospirone.


The risk or severity of adverse effects can be increased when pergolide is combined with omeprazole.


The risk or severity of adverse effects can be increased when labetalol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when rizatriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when labetalol is combined with lisinopril.


The risk or severity of adverse effects can be increased when temazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when indapamide is combined with penbutolol.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with procaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when procaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when phentolamine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with methazolamide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with carisoprodol.


The risk or severity of adverse effects can be increased when procaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Salsalate is combined with DESONIDE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with sulpiride.


The risk or severity of adverse effects can be increased when phenobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Olaparib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Metipranolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Retigabine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when clozapine is combined with atenolol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Quinupristin.


The risk or severity of adverse effects can be increased when citalopram is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when midazolam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Butoconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with rasagiline.


The risk or severity of adverse effects can be increased when temazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with levodopa.


The risk or severity of adverse effects can be increased when tizanidine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when amisulpride is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Trospium is combined with oxycodone.


The risk or severity of adverse effects can be increased when Tixocortol is combined with tubocurarine.


The risk or severity of adverse effects can be increased when cerulenin is combined with nicardipine.


The risk or severity of adverse effects can be increased when clonazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when diflorasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with prilocaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with risperidone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when morphine is combined with prilocaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Normethadone.


The risk or severity of adverse effects can be increased when clozapine is combined with sotalol.


The risk or severity of adverse effects can be increased when butabarbital is combined with etizolam.


The risk or severity of adverse effects can be increased when midazolam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when captopril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with bepridil.


The risk or severity of adverse effects can be increased when isoflurane is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when buspirone is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with ethotoin.


The risk or severity of adverse effects can be increased when captopril is combined with nabumetone.


The risk or severity of adverse effects can be increased when ibuprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when ropinirole is combined with terazosin.


The risk or severity of adverse effects can be increased when captopril is combined with ketorolac.


The risk or severity of adverse effects can be increased when imipramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when decamethonium is combined with Varenicline.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with ibuprofen.


The risk or severity of adverse effects can be increased when terconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when halothane is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when nicergoline is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when halothane is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when estazolam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when tioconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with thiopental.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when Olmesartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Clobetasone.